203 related articles for article (PubMed ID: 10753626)
1. Serum amyloid A is a chemotactic agonist at FPR2, a low-affinity N-formylpeptide receptor on mouse neutrophils.
Liang TS; Wang JM; Murphy PM; Gao JL
Biochem Biophys Res Commun; 2000 Apr; 270(2):331-5. PubMed ID: 10753626
[TBL] [Abstract][Full Text] [Related]
2. Synthetic peptide MMK-1 is a highly specific chemotactic agonist for leukocyte FPRL1.
Hu JY; Le Y; Gong W; Dunlop NM; Gao JL; Murphy PM; Wang JM
J Leukoc Biol; 2001 Jul; 70(1):155-61. PubMed ID: 11435499
[TBL] [Abstract][Full Text] [Related]
3. Amyloid-beta induces chemotaxis and oxidant stress by acting at formylpeptide receptor 2, a G protein-coupled receptor expressed in phagocytes and brain.
Tiffany HL; Lavigne MC; Cui YH; Wang JM; Leto TL; Gao JL; Murphy PM
J Biol Chem; 2001 Jun; 276(26):23645-52. PubMed ID: 11316806
[TBL] [Abstract][Full Text] [Related]
4. N-formylpeptides induce two distinct concentration optima for mouse neutrophil chemotaxis by differential interaction with two N-formylpeptide receptor (FPR) subtypes. Molecular characterization of FPR2, a second mouse neutrophil FPR.
Hartt JK; Barish G; Murphy PM; Gao JL
J Exp Med; 1999 Sep; 190(5):741-7. PubMed ID: 10477558
[TBL] [Abstract][Full Text] [Related]
5. The HIV-1 cell entry inhibitor T-20 potently chemoattracts neutrophils by specifically activating the N-formylpeptide receptor.
Hartt JK; Liang T; Sahagun-Ruiz A; Wang JM; Gao JL; Murphy PM
Biochem Biophys Res Commun; 2000 Jun; 272(3):699-704. PubMed ID: 10860818
[TBL] [Abstract][Full Text] [Related]
6. The endogenous opioid spinorphin blocks fMet-Leu-Phe-induced neutrophil chemotaxis by acting as a specific antagonist at the N-formylpeptide receptor subtype FPR.
Liang TS; Gao JL; Fatemi O; Lavigne M; Leto TL; Murphy PM
J Immunol; 2001 Dec; 167(11):6609-14. PubMed ID: 11714831
[TBL] [Abstract][Full Text] [Related]
7. A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells.
Su SB; Gong W; Gao JL; Shen W; Murphy PM; Oppenheim JJ; Wang JM
J Exp Med; 1999 Jan; 189(2):395-402. PubMed ID: 9892621
[TBL] [Abstract][Full Text] [Related]
8. Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation.
Le Y; Gong W; Li B; Dunlop NM; Shen W; Su SB; Ye RD; Wang JM
J Immunol; 1999 Dec; 163(12):6777-84. PubMed ID: 10586077
[TBL] [Abstract][Full Text] [Related]
9. A new insight into the role of "old" chemotactic peptide receptors FPR and FPRL1: down-regulation of chemokine receptors CCR5 and CXCR4.
Le Y; Shen W; Li B; Gong W; Dunlop NM; Wang JM
Forum (Genova); 1999; 9(4):299-314. PubMed ID: 10611407
[TBL] [Abstract][Full Text] [Related]
10. T21/DP107, A synthetic leucine zipper-like domain of the HIV-1 envelope gp41, attracts and activates human phagocytes by using G-protein-coupled formyl peptide receptors.
Su SB; Gao Jl; Gong Wh; Dunlop NM; Murphy PM; Oppenheim JJ; Wang JM
J Immunol; 1999 May; 162(10):5924-30. PubMed ID: 10229829
[TBL] [Abstract][Full Text] [Related]
11. Bacterial lipopolysaccharide selectively up-regulates the function of the chemotactic peptide receptor formyl peptide receptor 2 in murine microglial cells.
Cui YH; Le Y; Gong W; Proost P; Van Damme J; Murphy WJ; Wang JM
J Immunol; 2002 Jan; 168(1):434-42. PubMed ID: 11751990
[TBL] [Abstract][Full Text] [Related]
12. The FPR2-specific ligand MMK-1 activates the neutrophil NADPH-oxidase, but triggers no unique pathway for opening of plasma membrane calcium channels.
Karlsson J; Stenfeldt AL; Rabiet MJ; Bylund J; Forsman HF; Dahlgren C
Cell Calcium; 2009 May; 45(5):431-8. PubMed ID: 19282028
[TBL] [Abstract][Full Text] [Related]
13. F2L, a peptide derived from heme-binding protein, chemoattracts mouse neutrophils by specifically activating Fpr2, the low-affinity N-formylpeptide receptor.
Gao JL; Guillabert A; Hu J; Le Y; Urizar E; Seligman E; Fang KJ; Yuan X; Imbault V; Communi D; Wang JM; Parmentier M; Murphy PM; Migeotte I
J Immunol; 2007 Feb; 178(3):1450-6. PubMed ID: 17237393
[TBL] [Abstract][Full Text] [Related]
14. N-terminus urea-substituted chemotactic peptides: new potent agonists and antagonists toward the neutrophil fMLF receptor.
Higgins JD; Bridger GJ; Derian CK; Beblavy MJ; Hernandez PE; Gaul FE; Abrams MJ; Pike MC; Solomon HF
J Med Chem; 1996 Mar; 39(5):1013-5. PubMed ID: 8676333
[No Abstract] [Full Text] [Related]
15. The anti-infective peptide, innate defense-regulator peptide, stimulates neutrophil chemotaxis via a formyl peptide receptor.
Lee HY; Bae YS
Biochem Biophys Res Commun; 2008 May; 369(2):573-8. PubMed ID: 18294454
[TBL] [Abstract][Full Text] [Related]
16. A high potency nonformylated peptide agonist for the phagocyte N-formylpeptide chemotactic receptor.
Gao JL; Becker EL; Freer RJ; Muthukumaraswamy N; Murphy PM
J Exp Med; 1994 Dec; 180(6):2191-7. PubMed ID: 7964494
[TBL] [Abstract][Full Text] [Related]
17. The N-formylpeptide receptor (FPR) and a second G(i)-coupled receptor mediate fMet-Leu-Phe-stimulated activation of NADPH oxidase in murine neutrophils.
Lavigne MC; Murphy PM; Leto TL; Gao JL
Cell Immunol; 2002; 218(1-2):7-12. PubMed ID: 12470609
[TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of N-formylpeptide-induced neutrophil activation by carbamate-modified peptide analogues.
Derian CK; Solomon HF; Higgins JD; Beblavy MJ; Santulli RJ; Bridger GJ; Pike MC; Kroon DJ; Fischman AJ
Biochemistry; 1996 Jan; 35(4):1265-9. PubMed ID: 8573582
[TBL] [Abstract][Full Text] [Related]
19. Serum amyloid A inhibits apoptosis of human neutrophils via a P2X7-sensitive pathway independent of formyl peptide receptor-like 1.
Christenson K; Björkman L; Tängemo C; Bylund J
J Leukoc Biol; 2008 Jan; 83(1):139-48. PubMed ID: 17962368
[TBL] [Abstract][Full Text] [Related]
20. Formylpeptide receptor FPR and the rapid growth of malignant human gliomas.
Zhou Y; Bian X; Le Y; Gong W; Hu J; Zhang X; Wang L; Iribarren P; Salcedo R; Howard OM; Farrar W; Wang JM
J Natl Cancer Inst; 2005 Jun; 97(11):823-35. PubMed ID: 15928303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
